Featured Research

from universities, journals, and other organizations

Antidepressant Drug Tested In Treatment Of Bladder Disease

Date:
March 9, 2005
Source:
Queen's University
Summary:
Queen’s University has been selected as the only Canadian site to test a new antidepressant drug approved by the FDA (U.S. Food and Drug Administration) for its potential to alleviate pain in two common bladder conditions that have no known cause and no effective therapy.

Dr. Curtis Nickel.
Credit: Photo courtesy of Queen's University

Kingston, ON – Queen’s University has been selected as the only Canadian site to test a new antidepressant drug approved by the FDA (U.S. Food and Drug Administration) for its potential to alleviate pain in two common bladder conditions that have no known cause and no effective therapy.

Funded by the U.S. National Institutes of Health (NIH), the research will be carried out at 10 medical centres in the United States and Canada. Dr. Curtis Nickel, professor of Urology at Queen’s and urologist at Kingston General Hospital, heads the Canadian study.

The researchers are recruiting adults newly diagnosed with either painful bladder syndrome (PBS) or interstitial cystitis (IC), to learn if the oral drug amitriptyline will reduce the pain and frequent urination associated with these conditions. An estimated 10 million people worldwide suffer from PBS and IC.

Although amitriptyline is primarily used for depression, the way it works makes it useful fortreating the pain of fibromyalgia, multiple sclerosis, and other chronic pain syndromes, Dr. Nickel explains. “Prior small studies have suggested the drug may be a wise choice for this syndrome as well, because it blocks nerve signals that trigger pain and may also decrease muscle spasms in the bladder, helping to cut both pain and frequent urination.”

The researchers believe that 25 to 75 milligrams of amitriptyline a day may begin relieving IC pain within a week. In contrast, doses in the range of 150 to 300 milligrams are generally used to treat depression.

The 10 centres where testing will take place make up the Interstitial Cystitis Clinical Research Network, sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the NIH, which coordinates all government health care research in the United States.

In 2003, Dr. Nickel and his Kingston Genito-urinary Research Group were awarded an unprecedented four research grants from the NIH, totaling almost $8 million. These studies are now examining alternative, complementary and novel therapies for prostate and bladder disease, in both laboratory research and clinical trials involving more than 3,000 men and women throughout southern Ontario.


Story Source:

The above story is based on materials provided by Queen's University. Note: Materials may be edited for content and length.


Cite This Page:

Queen's University. "Antidepressant Drug Tested In Treatment Of Bladder Disease." ScienceDaily. ScienceDaily, 9 March 2005. <www.sciencedaily.com/releases/2005/03/050308100756.htm>.
Queen's University. (2005, March 9). Antidepressant Drug Tested In Treatment Of Bladder Disease. ScienceDaily. Retrieved July 31, 2014 from www.sciencedaily.com/releases/2005/03/050308100756.htm
Queen's University. "Antidepressant Drug Tested In Treatment Of Bladder Disease." ScienceDaily. www.sciencedaily.com/releases/2005/03/050308100756.htm (accessed July 31, 2014).

Share This




More Health & Medicine News

Thursday, July 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Xtreme Eating: Your Daily Caloric Intake All On One Plate

Xtreme Eating: Your Daily Caloric Intake All On One Plate

Newsy (July 30, 2014) The Center for Science in the Public Interest released its 2014 list of single meals with whopping calorie counts. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins